In contrast, they became stronger when only type 4 and NASH-HCC patients were used (p = 2.9x10−34 for rs2896019 and p = 2.0x10−8 for rs4808199, respectively), but the association of GCKR was lost (S2 Table). This evidence concerns the gene GCKR and metabolic dysfunction-associated steatohepatitis.